330 filings
Page 14 of 17
UPLOAD
4jcvsiee lfnz7m0l
17 Nov 06
Letter from SEC
12:00am
CORRESP
r965102urthpizx
2 Nov 06
Correspondence with SEC
12:00am
8-K
p4nt8w804xtummn
27 Oct 06
Results of Operations and Financial Condition
12:00am
UPLOAD
3ctkuazl mbx
19 Oct 06
Letter from SEC
12:00am
CORRESP
qncrhgkmavmtvg3qe
26 Sep 06
Correspondence with SEC
12:00am
UPLOAD
yyd43 dmg2zsz8cd9z2h
13 Sep 06
Letter from SEC
12:00am
8-K
4nudnd1vd61bx8du
8 Sep 06
Entry into a Material Definitive Agreement
12:00am
8-K
xgbx5n6tx
3 Aug 06
Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
12:00am
8-K
oq5g9xt0
28 Jun 06
Entry into a Material Definitive Agreement
12:00am
8-K
afu z02vs
2 May 06
Idenix Pharmaceuticals Reports First Quarter Financial Results
12:00am
8-K
sxbr1rokkwbenik2qou1
29 Mar 06
Idenix Announces Licensing of Valopicitabine (NM283) by Novartis
12:00am
8-K
gi06gh 5770rbjlaa2
23 Mar 06
Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C
12:00am
POS AM
fy0msls37xqov
15 Mar 06
Prospectus update (post-effective amendment)
12:00am
8-K
8p3fa7
13 Mar 06
Entry into a Material Definitive Agreement
12:00am